Explorer les evidences

463 patientsAmong dually seropositive patients, 463 were on antiretroviral therapy (ART).

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

25 %Nine out of 36 HIV-infected patients died, representing a mortality rate of 25%.

Côte d'IvoireVIH/sidaobservé January 2005-July 2015publié 2018The Pan African medical journaleurope_pmcdocument de 9 observations

7 casesOf the 1023 HIV-1-infected adults randomized in the Temprano deferred-ART group, seven (0.7%) were elite controllers.

Côte d'IvoireVIH/sidapublié 2022AIDS (London, England)europe_pmcdocument de 3 observations

1,42 per_100_person_monthsDuring the pre-intervention period, the malaria incidence rate was 1.42 cases per 100 person-months in the LLIN-alone control group.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

A multi-centric trial conducted in Kenya and Ethiopia reported no significant overall epidemiological impact of a Bti-based intervention on infection prevalence in school-aged children.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

25 monthsThe median follow-up duration was 25 months (interquartile range 19–31 months) among HBeAg-negative HIV/HBV co-infected patients in Côte d'Ivoire.

Côte d'Ivoirehépatite B · VIH/sidapublié 2019Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 4 observations

11 %The transmission dynamics model predicted a reduction in all-age clinical incidence of malaria of 11% to 78% across villages in Côte d'Ivoire.

Côte d'Ivoirepaludismepublié 2025PLoS pathogensPubMeddocument de 5 observations

14 480 deaths_per_yearAcross setting-scenarios, there was a mean of 14,480 deaths per year over 50 years with the switch policy in a setting with an adult population of 10 million in 2024.

Côte d'IvoireVIH/sidapublié 2025The lancet. HIVeurope_pmcdocument de 6 observations

40 %The intervention reduced malaria case prevalence by 40% in community cross-sectional surveys.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

1 per_100_person_weeksAmong children under five years of age, malaria incidence exceeded 1 case per 100 person-weeks during peaks in the late rainy season (November 2016).

Côte d'Ivoirepaludismeobservé November 2016HAL · Unilimdocument de 122 observations

3 casesThree cases of visceral leishmaniasis were reported in non-HIV infected native patients in Côte d'Ivoire.

Côte d'Ivoirevisceral leishmaniasispublié 2008Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument de 4 observations

7,92 aHRCavitation on chest x-ray was independently associated with mortality (aHR = 7.92, 95% CI, 1.74–35.94, p = .0073).

Côte d'Ivoiretuberculosepublié 2025BMC infectious diseaseseurope_pmcdocument de 9 observations

50,7 %A seropositivity to HIV1 and/or HIV2 was observed in 98 (50.7%) of patients with severe pulmonary tuberculosis in Ivory Coast from January to December 1987.

Côte d'IvoireHIV1 and/or HIV2observé 1987publié 1989PubMedOpenAlexdocument de 10 observations

66,6 %QFT-GIT specificity for active TB was 66.6%.

Côte d'Ivoiretuberculosepublié 2014PloS oneeurope_pmcdocument de 8 observations

68,6 %68.6% of the patients were on antiretroviral therapy (ART).

Côte d'IvoireVIH/sidaobservé 2012publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 8 observations

25 %At month 12 after ART initiation, 25% of patients in active follow-up had detectable viral loads.

Côte d'IvoireVIH/sidapublié 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 11 observations

10 000 copies/mLChronic HBeAg-negative HBV infection phase was defined as HBV DNA ≤10,000 copies/mL and normal alanine aminotransferase (ALT).

Côte d'Ivoirehépatite Bpublié 2019Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 4 observations

135 individualsAmong 190 HBsAg-positive participants, 135 (71%) had HBV DNA+.

Côte d'Ivoirehépatite Bpublié 2021Antiviral therapyeurope_pmcdocument de 4 observations

26,6 %Only 34 patients (26.6%) returned for clinical and biological post-exposure follow-up with HIV control at third month, without documented seroconversion.

Côte d'IvoireVIH/sidaobservé 2000-2007publié 2010Medecine et maladies infectieuseseurope_pmcdocument de 13 observations

4 yearsMedian duration of antiretroviral therapy was 4 years.

Côte d'IvoireVIH/sidapublié 2014AIDS (London, England)europe_pmcdocument de 9 observations

82,9 %82.9% of AEB victims consulted before the 48th hour.

Côte d'Ivoireaccidental exposure to bloodobservé January 2000 to December 2005publié 2007Medecine et maladies infectieuseseurope_pmcdocument de 11 observations

182 casesOne hundred eighty-two accidental exposures to blood (AEB) were managed over 6 years at the Infectious and Tropical Diseases Center of the Treichville University Hospital in Abidjan between January 2000 and December 2005.

Côte d'Ivoireaccidental exposure to bloodobservé January 2000 to December 2005publié 2007Medecine et maladies infectieuseseurope_pmcdocument de 11 observations

14,5 %The prevalence of periodontitis among female sex workers in Abidjan, Côte d'Ivoire was 14.5%.

Côte d'Ivoireperiodontitisobservé 2013publié 2015BMC oral healtheurope_pmcdocument de 7 observations

2,9 log10 copies/million PBMCThe median pre-antiretroviral treatment HIV-1 DNA level was 2.9 log10 copies per million PBMC among 1013 patients in the Temprano trial conducted in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublié 2022BMC infectious diseaseseurope_pmcdocument de 3 observationsDOI 10.1186/s12879-022-07082-2

18,3 %Undetermined infectious encephalitis accounted for 18.3% of causes of death.

Côte d'Ivoireundetermined infectious encephalitispublié 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument de 16 observations